WART REMOVER (salicylic acid)
VERRUCA VULGARIS·+3
RITE AID CORP.
Indication
Hyperkeratosis
Hyperkeratosis refers to the abnormal thickening of the stratum corneum, the outermost layer of the epidermis, typically resulting from excess production of keratin or retention of corneocytes. Read more about Hyperkeratosis
117 drugs 45 manufacturers
Drugs that treat it
Common Hyperkeratosis therapies.
TRANS-VER-SAL PEDIAPATCH (salicylic acid)
VERRUCA VULGARIS·+3
DOAK DERM.
SALACTIC FILM (salicylic acid/collodion, flexible)
VERRUCA VULGARIS·+3
PEDINOL PHARM.
GORDOFILM (salicylic acid/lactic acid/collodion, flexible)
VERRUCA VULGARIS·+3
GORDON
CALLUS REMOVER (salicylic acid)
VERRUCA VULGARIS·+3
CVS
SALEX (salicylic acid)
VERRUCA VULGARIS·+3
VALEANT
SALEX (salicylic acid/ceramides 1,3,6-II)
VERRUCA VULGARIS·+3
VALEANT
SALEX (salicylic acid/ceramides 1,3,6-II)
VERRUCA VULGARIS·+3
VALEANT
EXFOLIATING MOISTURIZER (salicylic acid/urea/petrolatum,white)
VERRUCA VULGARIS·+3
Walgreen Co
Filter & compare in the drug finder →Opens the drug finder with Hyperkeratosis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHyperkeratosis refers to the abnormal thickening of the stratum corneum, the outermost layer of the epidermis, typically resulting from excess production of keratin or retention of corneocytes.
It primarily affects the integumentary system across diverse patient populations and can manifest as localized or generalized rough, scaly, thickened plaques, calluses, or papules.
Pathophysiologically, it arises as a protective physiologic response to chronic friction, or secondary to underlying inflammatory dermatoses, genetic disorders of cornification, or premalignant alterations.
Histologically, it is broadly subclassified into orthokeratotic hyperkeratosis, where keratinocyte maturation is preserved without retained nuclei, and parakeratotic hyperkeratosis, marked by retained cellular nuclei reflecting altered epidermal transit.
- nih.gov
Hyperkeratosis refers to the abnormal thickening of the stratum corneum, the outermost layer of the epidermis, typically resulting from excess production of keratin or retention of corneocytes It primarily affects the integumentary system across diverse patient populations and can manifest as localized or generalized rough, scaly, thickened plaques, calluses, or papules Pathophysiologically, it arises as a protective physiologic response to chronic friction, or secondary to underlying inflammato...
- nih.gov
Hyperkeratosis refers to the abnormal thickening of the stratum corneum, the outermost layer of the epidermis, typically resulting from excess production of keratin or retention of corneocytes
- clevelandclinic.org
It primarily affects the integumentary system across diverse patient populations and can manifest as localized or generalized rough, scaly, thickened plaques, calluses, or papules
- harvard.edu
It primarily affects the integumentary system across diverse patient populations and can manifest as localized or generalized rough, scaly, thickened plaques, calluses, or papules
- medicalnewstoday.com
Pathophysiologically, it arises as a protective physiologic response to chronic friction, or secondary to underlying inflammatory dermatoses, genetic disorders of cornification, or premalignant alterations
Personalize your experience
Follow Hyperkeratosis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.